Belgian Society of Medical Oncology
@mybsmo
Official Twitter account of the Belgian Society of Medical Oncology ๐ง๐ช #BSMO ๐งโโ๏ธ๐จโโ๏ธ๐ฉโ https://t.co/5MwQdZqdOT
ID:1358122926432792577
http://www.bsmo.be 06-02-2021 18:38:41
318 Tweets
326 Followers
124 Following
Follow People
Aleix Prat #PrecisionOncology
Head Oncology @hospitalclinic, CoFounder @RevealGenomics, TranslGenomics @IDIBAPS, Prof @UniBarcelona, Team @IOBoncologia, COI https://t.co/HZFOVJKZcd
Evandro de Azambuja, MD, PhD
Evandro de Azambuja, Breast cancer specialist @JulesBordet. ESMO Director of Membership 2023-2024. BSMO President 2023-2026.
MarleenKokLab
medical oncologist, breast cancer immunotherapy investigator, mother, PI and associate prof at NKI, happy in Amsterdam
ESMO - Eur. Oncology
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology communityโs work.
BIG against BC
Breast International Group - Facilitating and accelerating breast cancer research internationally
๐ข๐๏ธAdd to calendar! ๐
YO4YO Virtual Clinical Case Discussion session ESMO - Eur. Oncology #YOC
โ
'Approaching a genomic profiling report for choosing the next line of therapy' ๐งฌ
We will present and discuss the cases on Monday 27, 18.00 CEST
Big thanks to ESMO - Eur. Oncology #YOC for organizing
๐Management of Localized Colorectal Cancer
ASCO Educational Book
โ
A must-read excellent review๐
doi.org/10.1200/EDBK_4โฆ
Journal of Clinical Oncology JCO Oncology Practice Deniz Can Guven Yakup Ergรผn
Only in few days and ESMO - Eur. Oncology will launch its first virtual journal club (Wednesday 22 May 2024, at 6:30pm CET). Hope to see you all there! Benjamin Besse @ValentinaGuarneri Elsevier Annals of Oncology #journalclub #research #education OncoAlert
#ESMOBreast24 #ESMOAmbassadors
Day3๏ธโฃkicks off starting with a session on current + future standards for immunotherapy in #breastcancer
Dear colleague and our Antwerp expert pathologist #RobertoSalgado tackles markers for response to IO beyond PD-L1
ESMO - Eur. Oncology โฆOncoAlertโฉ
#ESMOBreast24 #ESMOAmbassadors
Prof โฆPhilippe Aftimos, MD ๎จโฉ provided a great overview of the implementation of novel endocrine therapies and combinations in metastatic #breastcancer
โฆESMO - Eur. Oncologyโฉ #bcsm โฆOncoAlertโฉ
Great recap of the randomized trials in the 2L+ HR+ MBC setting by Eva M Ciruelos. #ESMOBreast24 #ESMOAmbassadors ESMO - Eur. Oncology
Highlights of #ESMOYOC Meet your mentor session on burnout and balancing worklife Christine Desmedt Cristina Saura
โช๏ธ Positive NO
โช๏ธ Define your priorities
โช๏ธ Plan where you want to be in 10 years
โช๏ธ Build teams
โช๏ธ Quality not quantity
#ESMOBreast24 #ESMOAmbassadors
Negative results of Impassion132 of the addition of atezolizumab to chemotherapy in early relapse TNBC presented by Rebecca Dent . So much still needed for this population. #ESMOBreast24 #ESMOAmbassadors
Belgian Society of Medical Oncology newsletter is out! Kevin Punie Willem Lybaert @anneliesverbiest Barbara Hendrikx @christelfontaine @christinegennigens @cรฉdricvanmarcke [email protected] FlorenceVanRyckeghem
canva.com/design/DAGCHZBโฆ
First ESMO - Eur. Oncology virtual journal club on May 22 at 6pm. Experts will discuss important articles. Don't miss it!
esmo.org/meeting-calendโฆ Evandro de Azambuja, MD, PhD Benjamin Besse @PatriziaGiannatempo @ValentinaGaurnieri
The MONARCH 3 trial
Addition of abemaciclib to a nonsteroidal aromatase inhibitor (NSAI) as initial therapy for hormone receptor-positive, ๐งฌHER2-negative advanced #BreastCancer
โ
Significantly improved PFS and showed clinically meaningful improvement in OS
โก๏ธ particularly
Want to know more about the ADCs in lung and
and breast cancers ๐ค๐ค
A great review by the giants of the field to start ๐ฏ๐ฏ
โ๏ธSummary of the available data
โ๏ธA roadmap for further studies ๐๐
โ๏ธEmphasizing the need for collaborations and biomarker-driven approaches ๐๐
